| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PD.5049 |
| P8608 | Fatcat ID | release_lmvu4kbvcnearc5zifuoitq66i |
| P698 | PubMed publication ID | 28382695 |
| P50 | author | Steen Sørensen | Q57070245 |
| Tanja Schlaikjaer Hartwig | Q87769475 | ||
| P2093 | author name string | Finn Stener Jørgensen | |
| Louise Ambye | |||
| P2860 | cites work | Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis | Q28072788 |
| Accuracy of cytogenetic findings on chorionic villus sampling (CVS)--diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992 | Q28250247 | ||
| Origin of extraembryonic mesoderm in experimental animals: relevance to chorionic mosaicism in humans | Q28260141 | ||
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
| Copy-number variation and false positive prenatal aneuploidy screening results | Q30643919 | ||
| Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma | Q34336915 | ||
| Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing | Q34433169 | ||
| Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies | Q34484712 | ||
| A prenatal case with discrepant findings between non-invasive prenatal testing and fetal genetic testings | Q34631506 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Fetal Aneuploidy Detection by Cell-Free DNA Sequencing for Multiple Pregnancies and Quality Issues with Vanishing Twins | Q35667120 | ||
| Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18. | Q35763064 | ||
| Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes | Q35936608 | ||
| Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women | Q36354286 | ||
| Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities | Q36473401 | ||
| Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies | Q37325876 | ||
| Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling | Q37345805 | ||
| Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles | Q37418057 | ||
| A Case of False Negative NIPT for Down Syndrome-Lessons Learned | Q37598581 | ||
| Cell-free DNA testing in a trisomy 21 pregnancy with confined placental mosaicism for a cell line with trisomy for both chromosomes 18 and 21. | Q38801847 | ||
| Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy | Q38889509 | ||
| Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype | Q39019372 | ||
| Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. | Q39024055 | ||
| Vanishing twin as a potential source of bias in non-invasive fetal sex determination: a case report | Q39235307 | ||
| Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. | Q41566460 | ||
| Copy-Number Variation and False Positive Results of Prenatal Screening | Q42786115 | ||
| Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies | Q43524466 | ||
| Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease | Q44602113 | ||
| Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report | Q48004844 | ||
| Copy-Number Variation and False Positive Prenatal Screening Results. | Q50611196 | ||
| Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy. | Q50693778 | ||
| Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. | Q51025463 | ||
| Comment on "The importance of determining the limit of detection of non-invasive prenatal testing methods". | Q53775714 | ||
| The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. | Q54708648 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Two cases of placental T21 mosaicism: challenging the detection limits of non-invasive prenatal testing | Q57097369 | ||
| First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study | Q57285237 | ||
| Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘False positive’ due to confined placental mosaicism | Q58028950 | ||
| Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening | Q58133884 | ||
| P433 | issue | 6 | |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 527-539 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | Discordant non-invasive prenatal testing (NIPT) - a systematic review | |
| P478 | volume | 37 |
| Q97419367 | A rare Down syndrome foetus with de novo 21q;21q rearrangements causing false negative results in non-invasive prenatal testing: a case report |
| Q64055782 | An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study |
| Q89750467 | Analyzing false-negative results detected in low-risk non-invasive prenatal screening cases |
| Q87919240 | Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study |
| Q47351507 | Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results |
| Q91980501 | Detection of a rare de novo 18p terminal deletion with inverted duplication in a Chinese pregnant woman |
| Q61849284 | Ensuring high standards for the delivery of NIPT world-wide: Development of an international external quality assessment scheme |
| Q92899022 | Evaluation of non-invasive prenatal testing to detect chromosomal aberrations in a Chinese cohort |
| Q89866364 | Genetic diagnosis in the fetus |
| Q98178342 | Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution |
| Q93042108 | Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests |
| Q57774989 | Isochromosome 21q is overrepresented among false-negative cell-free DNA prenatal screening results involving Down syndrome |
| Q93048813 | Lower detectability of non-invasive prenatal testing compared to prenatal diagnosis in high-risk pregnant women |
| Q96576772 | Non-invasive prenatal testing leading to a maternal diagnosis of Charcot-Marie-Tooth neuropathy |
| Q55438251 | Noninvasive Prenatal Testing: Comparison of Two Mappers and Influence in the Diagnostic Yield. |
| Q92011829 | Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype |
| Q49973199 | Prenatal diagnosis by chromosomal microarray analysis |
| Q57788830 | Reliable detection of subchromosomal deletions and duplications using cell-based noninvasive prenatal testing |
| Q91790685 | Sequencing Shorter cfDNA Fragments Decreases the False Negative Rate of Non-invasive Prenatal Testing |
| Q58564726 | Small supernumerary marker chromosomes: A legacy of trisomy rescue? |
| Q57809468 | Strategies to minimize false positives and interpret novel microdeletions based on maternal copy-number variants in 87,000 noninvasive prenatal screens |
| Q91875022 | Targeted fetal cell-free DNA screening for aneuploidies in 4,594 pregnancies: Single center study |
| Q90295602 | The significance of the placental genome and methylome in fetal and maternal health |
Search more.